Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             57 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndrome (MDS) and Failure of Therapy with Hypomethylating Agents (HMA): An Emerging Entity With a Poor Prognosis Ghanem, Hady
2013
13 S2 p. S379-
1 p.
artikel
2 Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Oran, Betul
2013
13 S2 p. S282-S288
7 p.
artikel
3 Allogeneic Stem Cell Transplantation and Targeted Immunotherapy for Multiple Myeloma Danylesko, Ivetta
2013
13 S2 p. S330-S348
19 p.
artikel
4 Antagonizing IAPs by SMAC Mimetic Birinapant Induces Apoptosis in AML Cells Including AML Stem/Progenitor Cells Alone and in Combination With Chemotherapy in vitro and in vivo Carter, Bing Z.
2013
13 S2 p. S376-S377
2 p.
artikel
5 A Phase I/II Trial of Combination of PKC412 and 5-azacytidine (AZA) for the Treatment of Patients with Refractory or Relapsed (R/R) Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Nazha, Aziz
2013
13 S2 p. S374-S375
2 p.
artikel
6 A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients Vigil, Carlos E.
2013
13 S2 p. S380-
1 p.
artikel
7 ARC Is Regulated by MAPK and PI3K and Confers Drug Resistance and Survival Advantage to AML in vitro and in vivo Mak, Po Yee
2013
13 S2 p. S376-
1 p.
artikel
8 Are All Interferons the Same for Therapy in Polycythemia Vera? Silver, Richard T.
2013
13 S2 p. S305-S306
2 p.
artikel
9 Biological and Clinical Features of Trisomy 21 Acute Myeloid Leukemia Strati, Paolo
2013
13 S2 p. S375-S376
2 p.
artikel
10 Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia Strati, Paolo
2013
13 S2 p. S276-S281
6 p.
artikel
11 Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma Cervantes-Gomez, Fabiola
2013
13 S2 p. S317-S329
13 p.
artikel
12 Characteristics, Response to Therapy and Outcome of African American Patients With Chronic Lymphocytic Leukemia Falchi, Lorenzo
2013
13 S2 p. S363-S364
2 p.
artikel
13 Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) With Imatinib (IM) Intolerance or Resistant Disease - Response to Thalidomide (TALI) Treatment - Preliminary Report of a Serial of Cases With Encouraging Results Hurtado-Monroy, Rafael
2013
13 S2 p. S385-S386
2 p.
artikel
14 Clinical Implementation of a Novel High-Throughput Screen of Primary Leukemia Cells to Personalize Therapy for Relapsed/Refractory Acute Myeloid Leukemia (AML) Shum, David
2013
13 S2 p. S378-
1 p.
artikel
15 Clinical Implication of Discrepancy in the Diagnosis of Primary Myelofibrosis between Referral and Tertiary Center Yi, Cecilia Arana
2013
13 S2 p. S372-S373
2 p.
artikel
16 Combination of Pim Kinase Inhibitor SGI-1776 and Bendamustine in B-Cell Lymphoma Yang, Qingshan
2013
13 S2 p. S355-S362
8 p.
artikel
17 Comparison of Outcome in Erythroleukemia Patients Treated with Standard Chemotherapy Regimens or Hypomethylating Agents Vigil, Carlos E.
2013
13 S2 p. S380-S381
2 p.
artikel
18 Continuing Medical Education Post-Test[Course Code: MEMV 1116] 2013
13 S2 p. S387-S390
4 p.
artikel
19 Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome Ghanem, Hady
2013
13 S2 p. S289-S294
6 p.
artikel
20 Deletion 11q Abnormality in Patients With Chronic Lymphocytic Leukemia (CLL) May Not Have Poor Clinical Outcomes and Bulky Disease (Clinical and Radiological) at Presentation – Clinical Characteristics of (n=172) Previously Untreated Patients With CLL and del11q Cytogenetic Abnormality Jain, Preetesh
2013
13 S2 p. S365-
1 p.
artikel
21 Editorial Board/Masthead 2013
13 S2 p. A6-
1 p.
artikel
22 HCVAD plus Imatinib or Dasatinib for Lymphoid Blastic Phase of Chronic Myeloid Leukemia Strati, Paolo
2013
13 S2 p. S384-S385
2 p.
artikel
23 High-Throughput Sequencing to Detect Minimal Residual Disease in Acute T Lymphoblastic Leukemia Sherwood, Anna
2013
13 S2 p. S369-
1 p.
artikel
24 Hypoxia Activated Pro-Drug TH-302 Induces Hypoxia-Dependent Anti-leukemia Activity in vitro and in vivo Benito, Juliana M.
2013
13 S2 p. S377-
1 p.
artikel
25 In vitro Effect of AZD1208 (Pim Kinase Inhibitor) and 17-AAG (HSP90 Inhibitor) Combination in CLL Cervantes-Gomez, Fabiola
2013
13 S2 p. S366-
1 p.
artikel
26 Long Term Effect of Decitabine (DAC) Dose Delay (DD) and Dose Reduction (DR) on Survival and Progression of Patients (pts) with Myelodysplastic Syndrome (MDS) Ghanem, Hady
2013
13 S2 p. S374-
1 p.
artikel
27 Management of Cytopenias With Ruxolitinib Treatment in Patients With Myelofibrosis Verstovsek, Srdan
2013
13 S2 p. S371-
1 p.
artikel
28 Mutant NPM1 is a Reliable Marker of Minimal Residual Leukemia in Patients with Acute Myeloid Leukemia Jain, Preetesh
2013
13 S2 p. S378-S379
2 p.
artikel
29 Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study Xu-Monette, Zijun Y.
2013
13 S2 p. S382-
1 p.
artikel
30 MYC/BCL2 Protein Co-Expression Defines a Unique Subset of Aggressive Lymphoma and Contributes to the Inferior Prognosis of Activated B-cell Subtype of Diffuse Large B-cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study Hu, Shimin
2013
13 S2 p. S382-S383
2 p.
artikel
31 Novel Caspase-3 Activator, L14R8, Induces Apoptosis in CLL cells Patel, ViralKumar
2013
13 S2 p. S366-S367
2 p.
artikel
32 Novel Treatment Options for Waldenström Macroglobulinemia Leblebjian, Houry
2013
13 S2 p. S310-S316
7 p.
artikel
33 Other Cancers in Patients With Chronic Lymphocytic Leukemia Requiring Therapy: Association With Prognostic Factors and Impact on Survival Falchi, Lorenzo
2013
13 S2 p. S364-
1 p.
artikel
34 PACE: A Pivotal Phase 2 Trial of Ponatinib in Patients With CML and Ph+ ALL Resistant or Intolerant to Dasatinib or Nilotinib, or With the T315I Mutation Cortes, Jorge E.
2013
13 S2 p. S384-
1 p.
artikel
35 Phase II Study of Nelarabine With Hyper-CVAD in Patients With Previously Untreated T cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (LL) Jain, Preetesh
2013
13 S2 p. S368-S369
2 p.
artikel
36 Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older With Acute Myeloid Leukemia Jacoby, Meagan A.
2013
13 S2 p. S374-
1 p.
artikel
37 Phosphorylation of GSK3β is Prognostic for Inferior Survival in Acute Myeloid Leukemia Ruvolo, Peter
2013
13 S2 p. S375-
1 p.
artikel
38 Prognostic Factors and Risk Models in Myelodysplastic Syndromes Komrokji, Rami S.
2013
13 S2 p. S295-S299
5 p.
artikel
39 Rationale for Targeting the PI3K/Akt/mTOR Pathway in Myeloproliferative Neoplasms Bartalucci, Niccolò
2013
13 S2 p. S307-S309
3 p.
artikel
40 Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) on Peripheral Blood (PB) and Bone Marrow (BM) Samples for Monitoring Minimal Residual Disease (MRD) in Patients (pts) With Acute Promyelocytic Leukemia (APL) Treated With All-Trans-Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) Ghanem, H.
2013
13 S2 p. S377-S378
2 p.
artikel
41 Refined MD Anderson Prognostic Scoring System (MDAPS-R) for Chronic Myelomonocytic Leukemia (CMML) Takahashi, Koichi
2013
13 S2 p. S373-
1 p.
artikel
42 Relationship Between Ruxolitinib Dose and Improvements in Spleen Volume and Symptoms in Patients With Myelofibrosis: Results From COMFORT-I Mesa, Ruben A.
2013
13 S2 p. S371-S372
2 p.
artikel
43 Retrospect of Hematological Malignancies 2012 Freireich, Emil J.
2013
13 S2 p. S271-
1 p.
artikel
44 Role of Consolidation/Maintenance Therapy in Multiple Myeloma Palumbo, Antonio
2013
13 S2 p. S349-S354
6 p.
artikel
45 Second Cancers (SC) Affect the Clinical Outcome of Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Frontline FCR Therapy Benjamini, Ohad
2013
13 S2 p. S365-S366
2 p.
artikel
46 Second Generation TKIs Can Induce Complete Molecular Response in Ph-Positive Acute Lymphoblastic Leukemia After Allogeneic Stem Cell Transplant Fava, C.
2013
13 S2 p. S367-S368
2 p.
artikel
47 Second-Generation Tyrosine Kinase Inhibitors Can Induce Complete Molecular Response in Ph-Positive Acute Lymphoblastic Leukemia After Allogeneic Stem Cell Transplant Fava, Carmen
2013
13 S2 p. S272-S275
4 p.
artikel
48 Signal Transducer and Activator of Transcription (STAT)-3 Activates Nuclear Factor (NF)-κB in Primary Myelofibrosis (PMF) Bone Marrow Cells Grgurevic, Srdana
2013
13 S2 p. S370-S371
2 p.
artikel
49 Signal Transducer and Activator of Transcription (STAT)-3-Dependent Regulation of Non-Coding RNA in Small lymphocytic lymphoma/Chronic lymphocytic leukemia (CLL) Rozovski, Uri
2013
13 S2 p. S363-
1 p.
artikel
50 Successful Long-Term Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms With Combination of Hydroxyurea and Anagrelide Ahn, Inhye E.
2013
13 S2 p. S370-
1 p.
artikel
51 Successful Long-Term Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms With Combination of Hydroxyurea and Anagrelide Ahn, Inhye E.
2013
13 S2 p. S300-S304
5 p.
artikel
52 Table of Contents 2013
13 S2 p. A7-A8
nvt p.
artikel
53 Targeted Alpha-particle Nano-generator Actinium-225 (225Ac)-lintuzumab (anti-CD33) in Acute Myeloid Leukemia (AML) Jurcic, J.G.
2013
13 S2 p. S379-S380
2 p.
artikel
54 Targeting the Pro-Survival Protein c-MET With ARQ 197 Inhibits Growth of Multiple Myeloma Cells Zaman, Shadia
2013
13 S2 p. S381-
1 p.
artikel
55 The hsa-let-7a miRNA Enhances Ara-C Induced Apoptosis in Human Acute Myeloid Leukemia Cells Chen, Ye
2013
13 S2 p. S368-
1 p.
artikel
56 The Pro-apoptotic Effect of Kefir in Malignant T-lymphocytes Involves a p53 Dependent Pathway Rizk, Sandra
2013
13 S2 p. S367-
1 p.
artikel
57 Transcription and Translation are Primary Targets of Pim Kinase Inhibitor SGI-1776 in Mantle Cell Lymphoma Yang, Qingshan
2013
13 S2 p. S383-
1 p.
artikel
                             57 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland